トップキープレーヤーは次のとおりです。
Teva Pharmaceutical Industries Ltd.
Biocon
Pfizer Inc.
Amgen Inc
F. Hoffmann-La Roche AG
Dr. Reddy抯 Laboratories Ltd.
Sandoz International GmbH
Mylan N.V
Samsung Bioepis
1 Market Overview
1.1 Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Human Growth Hormone
1.2.2 Erythropoietin
1.2.3 Monoclonal Antibodies
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Granulocyte-Colony Stimulating Factor
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Oncology
1.3.2 Blood Disorders
1.3.3 Growth Hormonal Deficiency
1.3.4 Chronic and Autoimmune Disorders
1.3.5 Others
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Biosimilars Market Size Analysis from 2015 to 2028
1.6.1 Global Biosimilars Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Biosimilars Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Biosimilars Price Trends Analysis from 2015 to 2028
2 Global Biosimilars Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosimilars (Volume and Value) by Type
2.1.1 Global Biosimilars Consumption and Market Share by Type (2015-2020)
2.1.2 Global Biosimilars Revenue and Market Share by Type (2015-2020)
2.2 Global Biosimilars (Volume and Value) by Application
2.2.1 Global Biosimilars Consumption and Market Share by Application (2015-2020)
2.2.2 Global Biosimilars Revenue and Market Share by Application (2015-2020)
2.3 Global Biosimilars (Volume and Value) by Region
2.3.1 Global Biosimilars Consumption and Market Share by Region (2015-2020)
2.3.2 Global Biosimilars Revenue and Market Share by Region (2015-2020)
3 United States Biosimilars Market Analysis
3.1 United States Biosimilars Consumption and Value Analysis
3.2 United States Biosimilars Consumption Volume by Type
3.3 United States Biosimilars Consumption Structure by Application
4 Europe Biosimilars Market Analysis
4.1 Europe Biosimilars Consumption and Value Analysis
4.2 Europe Biosimilars Consumption Volume by Type
4.3 Europe Biosimilars Consumption Structure by Application
4.4 Europe Biosimilars Consumption by Top Countries
4.4.1 Germany Biosimilars Consumption Volume from 2015 to 2020
4.4.2 UK Biosimilars Consumption Volume from 2015 to 2020
4.4.3 France Biosimilars Consumption Volume from 2015 to 2020
4.4.4 Italy Biosimilars Consumption Volume from 2015 to 2020
4.4.5 Spain Biosimilars Consumption Volume from 2015 to 2020
4.4.6 Poland Biosimilars Consumption Volume from 2015 to 2020
4.4.7 Russia Biosimilars Consumption Volume from 2015 to 2020
5 China Biosimilars Market Analysis
5.1 China Biosimilars Consumption and Value Analysis
5.2 China Biosimilars Consumption Volume by Type
5.3 China Biosimilars Consumption Structure by Application
6 Japan Biosimilars Market Analysis
6.1 Japan Biosimilars Consumption and Value Analysis
6.2 Japan Biosimilars Consumption Volume by Type
6.3 Japan Biosimilars Consumption Structure by Application
7 Southeast Asia Biosimilars Market Analysis
7.1 Southeast Asia Biosimilars Consumption and Value Analysis
7.2 Southeast Asia Biosimilars Consumption Volume by Type
7.3 Southeast Asia Biosimilars Consumption Structure by Application
7.4 Southeast Asia Biosimilars Consumption by Top Countries
7.4.1 Indonesia Biosimilars Consumption Volume from 2015 to 2020
7.4.2 Thailand Biosimilars Consumption Volume from 2015 to 2020
7.4.3 Philippines Biosimilars Consumption Volume from 2015 to 2020
7.4.4 Malaysia Biosimilars Consumption Volume from 2015 to 2020
7.4.5 Singapore Biosimilars Consumption Volume from 2015 to 2020
7.4.6 Vietnam Biosimilars Consumption Volume from 2015 to 2020
8 India Biosimilars Market Analysis
8.1 India Biosimilars Consumption and Value Analysis
8.2 India Biosimilars Consumption Volume by Type
8.3 India Biosimilars Consumption Structure by Application
9 Brazil Biosimilars Market Analysis
9.1 Brazil Biosimilars Consumption and Value Analysis
9.2 Brazil Biosimilars Consumption Volume by Type
9.3 Brazil Biosimilars Consumption Structure by Application
10 GCC Countries Biosimilars Market Analysis
10.1 GCC Countries Biosimilars Consumption and Value Analysis
10.2 GCC Countries Biosimilars Consumption Volume by Type
10.3 GCC Countries Biosimilars Consumption Structure by Application
10.4 GCC Countries Biosimilars Consumption Volume by Major Countries
10.4.1 Saudi Arabia Biosimilars Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Biosimilars Consumption Volume from 2015 to 2020
10.4.3 Qatar Biosimilars Consumption Volume from 2015 to 2020
10.4.4 Bahrain Biosimilars Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Teva Pharmaceutical Industries Ltd. Biosimilars Sales, Price, Revenue, Gross Margin
11.1.4 Teva Pharmaceutical Industries Ltd. Biosimilars Sales by Region
11.2 Biocon
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Biocon Biosimilars Sales, Price, Revenue, Gross Margin
11.2.4 Biocon Biosimilars Sales by Region
11.3 Pfizer Inc.
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Pfizer Inc. Biosimilars Sales, Price, Revenue, Gross Margin
11.3.4 Pfizer Inc. Biosimilars Sales by Region
11.4 Amgen Inc
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 Amgen Inc Biosimilars Sales, Price, Revenue, Gross Margin
11.4.4 Amgen Inc Biosimilars Sales by Region
11.5 F. Hoffmann-La Roche AG
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 F. Hoffmann-La Roche AG Biosimilars Sales, Price, Revenue, Gross Margin
11.5.4 F. Hoffmann-La Roche AG Biosimilars Sales by Region
11.6 Dr. Reddy抯 Laboratories Ltd.
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Dr. Reddy抯 Laboratories Ltd. Biosimilars Sales, Price, Revenue, Gross Margin
11.6.4 Dr. Reddy抯 Laboratories Ltd. Biosimilars Sales by Region
11.7 Sandoz International GmbH
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Sandoz International GmbH Biosimilars Sales, Price, Revenue, Gross Margin
11.7.4 Sandoz International GmbH Biosimilars Sales by Region
11.8 Mylan N.V
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Mylan N.V Biosimilars Sales, Price, Revenue, Gross Margin
11.8.4 Mylan N.V Biosimilars Sales by Region
11.9 Samsung Bioepis
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Samsung Bioepis Biosimilars Sales, Price, Revenue, Gross Margin
11.9.4 Samsung Bioepis Biosimilars Sales by Region
13 Global Biosimilars Market Forecast (2020-2028)
13.1 Global Biosimilars Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Biosimilars Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Biosimilars Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Biosimilars Price and Trend Forecast (2020-2028)
13.2 Global Biosimilars Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Biosimilars Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Biosimilars Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Biosimilars Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Biosimilars Consumption Forecast by Type (2020-2028)
13.3.2 Global Biosimilars Revenue Forecast by Type (2020-2028)
13.3.3 Global Biosimilars Price Forecast by Type (2020-2028)
13.4 Global Biosimilars Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
